KIT and neoplasm: Exome sequencing of the tumor identified the following genomic alterations: PIK3CA E542K mutation, PTEN loss, CDK4 amplification, TP53 H179R mutation, KIT amplification, PDGFRA amplification, KDR amplification, and NOTCH2 exon 3 truncation.